国家自然科学基金3项（在研1项）、江苏省重点研发计划（临床前沿技术）1项（在研）、南京市医学科研发展重点项目3项等（在研1项）。

1. Rong D, Lu C, Zhang B, Fu K, Zhao S*, Tang W*, Cao H*. CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p. Mol Cancer. 2019 Feb 18;18(1):25.
2. Xuefeng Zhang, Jing Wang, Jing Lu, Rongrong Li and Shuli Zhao*. Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates. Virology Journal (2018) 15:111.
3. Jiaojiao Zhao, Yaxian Xue, Yuchen Pan, Anran Yao, Guoqun Wang, Dan Li, Tingting Wang, Shuli Zhao* and Yayi Hou*. Toll‐like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3‐UNC93B1‐IFN‐β signaling axis in paclitaxel‐resistant colon cancer. J Cell Physiol. 2019 May;234(5):7051-7061.
4. Jiaojiao Zhao, Zhengkui Zhang, Yaxian Xue, Guoqun Wang, Yuan Cheng, Yuchen Pan, Shuli Zhao* and Yayi Hou. Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly(I:C) promote melanoma regression. Theranostics 2018, Vol. 8, Issue 22.
5. Li Y#, Yang Y#, Xiong A, Wu X, Xie J, Han S, Zhao S*. Comparative Gene Expression Analysis of Lymphocytes Treated with Exosomes Derived from Ovarian Cancer and Ovarian Cysts. Front Immunol. 2017 Jun 1;8:607.
6. Zhao J#, Pan Y, Li X, Zhang X, Xue Y, Wang T, Zhao S*, Hou Y*. Dihydroartemisinin and Curcumin Synergistically Induce Apoptosis in SKOV3 Cells Via Upregulation of MiR-124 Targeting Midkine. Cell Physiol Biochem. 2017;43(2):589-601.
7. Zhang D#, Ding L, Li Y, Ren J, Shi G, Wang Y, Zhao S*, Ni Y*, Hou Y*. Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells. Sci Rep. 2017 Nov 24;7(1):16231.
8. Shuli Zhao#, Zhengtao Chu, Victor M. Blanco,Yunzhong Nie,Yayi Hou, Xiaoyang Qi. SapC–DOPS Nanovesicles as Targeted Therapy for Lung Cancer. Mol Cancer Ther; 2015, 14(2); 491–8.
9. Xiaoqing Wu, Xiaogai Zhi, Minghua Ji, Qingling Wang, Yujuan Li, Jingyan Xie* and Shuli Zhao*. Midkine as a potential diagnostic marker in epithelial ovarian cancer for cisplatin/paclitaxel combination clinical therapy. American Journal of Cancer Research. 2015,15;5(2):629-38.
10. Ren J, Nie Y, Lv M, Shen S, Tang R, Xu Y, Hou Y, Zhao S*, Wang T*. Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17. Cell Mol Immunol. 2015 Nov;12(6):768-76.
11. Xie J, Liu M, Li Y, Nie Y, Mi Q, Zhao S*. Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression. Cell Mol Immunol. 2014 Sep;11(5):495-502.
12. Zhao SL#, Zhang YJ#, Li MH, Zhang XL, Chen SL. Mesenchymal stem cells with overexpression of midkine enhance cell survival and attenuate cardiac dysfunction in a rat model of myocardial infarction.Stem Cell Res Ther. 2014 Mar 17;5(2):37

授权专利：获得美国发明专利1项，中国发明专利4项